Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs
Curr Med Res Opin. 2009 Apr;25(4):869-77
Authors
Birnbaum HG, Ivanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, Meletiche D